These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 590978)

  • 61. [Normalizing effect of arginine thiazolidincarboxylate (ATCA) on hepatocytes in CCL4 poisoning in rats].
    Marcucci A; Ferrario F; Carminati R; Falchi M; Dubini F
    Farmaco Prat; 1980 Jun; 35(6):286-93. PubMed ID: 7449949
    [No Abstract]   [Full Text] [Related]  

  • 62. Cytoplasmic aggregates in D-galactosamine induced liver injury.
    Tompa A; Lapis K; Schaff Z; Mészáros K; Mandl J; Garzó T; Antoni F
    Acta Morphol Acad Sci Hung; 1977; 25(4):239-57. PubMed ID: 617770
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study on di-L(+)-ornithine-alpha-ketoglutaric acid in the model of isolated perfused rat liver].
    Róka L; Miertsch HJ
    Arzneimittelforschung; 1972 Jul; 22(7):1103-9. PubMed ID: 4678115
    [No Abstract]   [Full Text] [Related]  

  • 64. [High-dose intavenous administration of arginine-malate combined with cytidine and uridine in the treatment of chronic liver diseases].
    Barlattani M; De Martiis M; Messina B
    Clin Ter; 1974 Aug; 70(4):323-36. PubMed ID: 4609677
    [No Abstract]   [Full Text] [Related]  

  • 65. Aggravating and protecting effects of triton and corticosteroids in galactosamine-induced hepatitis.
    Grases PJ; Lesch R; Stein U; Heissmeyer H; Reutter W
    G E N; 1972; 27(1):77-89. PubMed ID: 4632028
    [No Abstract]   [Full Text] [Related]  

  • 66. [Aggravation of acute galactosamine hepatitis by a sodic bicarbonated water in rats (author's transl)].
    de La Tour J; Souchard M; Chariot J; Rozé C; Potet F; Vaille C
    J Pharmacol; 1981; 12(1):37-50. PubMed ID: 6261045
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The biochemical pathology of liver cell necrosis.
    Farber JL; El-Mofty SK
    Am J Pathol; 1975 Oct; 81(1):237-50. PubMed ID: 1180333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication.
    Wands JR; Carter EA; Bucher NL; Isselbacher KJ
    Gastroenterology; 1979 Sep; 77(3):528-31. PubMed ID: 572315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The anti-hepatotoxic effect of parenterally administered silymarin in CCl4-induced liver damage of the rat].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1973 Jan; 23():Suppl:148-9. PubMed ID: 4740683
    [No Abstract]   [Full Text] [Related]  

  • 70. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Undesirable metabolic effects following the administration of larger doses of fructose and sorbitol].
    Bode JC
    Infusionstherapie (1973); 1974 Oct; 1(7):558-63. PubMed ID: 4219394
    [No Abstract]   [Full Text] [Related]  

  • 72. [Experimental drug therapy of toxic hepatitis].
    Lershin BI
    Patol Fiziol Eksp Ter; 1972; 16(2):66-7. PubMed ID: 5044394
    [No Abstract]   [Full Text] [Related]  

  • 73. [Experimental therapy of toxic hepatitis with hydrocortisone].
    Iakobson GS; Leont'eva LI; Osokina GP; Hosova LV; Proskuriakova IS
    Patol Fiziol Eksp Ter; 1971; 15(1):84-6. PubMed ID: 5141939
    [No Abstract]   [Full Text] [Related]  

  • 74. [Immunostimulant action of thiamine in toxic lesions of the liver].
    Konoplia AI
    Patol Fiziol Eksp Ter; 1977; (6):54-9. PubMed ID: 600577
    [No Abstract]   [Full Text] [Related]  

  • 75. [Letter: Silymarine against acute degenerative hepatitis in mice induced by FV 3. Experimental study of its activity].
    Kirn A; Gut JP; Gendrault JL
    Nouv Presse Med; 1974 Sep; 3(31):1960. PubMed ID: 4374682
    [No Abstract]   [Full Text] [Related]  

  • 76. [Transumbilical introduction of medicinal substances in clinical toxicology].
    Luzhnikov EA; Shimanko II; Kosarev VA; Tsukhishvili NA; Musselius SG
    Klin Med (Mosk); 1972 Jul; 50(7):34-6. PubMed ID: 5052637
    [No Abstract]   [Full Text] [Related]  

  • 77. Role of uridine entrapped in liposomes in galactosamine-induced hepatitis.
    Mathias C; Dorai DT; Bachhawat BK
    Indian J Biochem Biophys; 1977 Jun; 14(2):142-6. PubMed ID: 590978
    [No Abstract]   [Full Text] [Related]  

  • 78. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 79. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
    Liehr H; Heine WD
    Hepatogastroenterology; 1981 Dec; 28(6):296-8. PubMed ID: 7345010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.